Quest Diagnostics SUSPENDS PARTICIPATION in the Hawaii Pre-Travel Testing Program, effective November 22, 2020

Due to high demand from healthcare providers for our COVID-19 molecular diagnostic testing services, Quest Diagnostics is suspending its participation in the Hawaii Pre-travel Testing Program, effective November 22, 2020.

We will perform testing for any purchase that has already been made for a QuestDirect Active Infection drive-thru test. Please note that we encourage individuals who received a QuestDirect Active Infection test at a Walmart location to have their test result in hand upon boarding for your trip to Hawaii.
Click here for important new information about Hawaii’s Pre-travel Testing Program.

We realize the inconvenience this suspension may cause. Healthcare providers and hospitals increasingly rely on Quest Diagnostics for COVID-19 molecular diagnostic testing on behalf of patients, given a surge in COVID-19 cases across the United States.

If you have any concerns or questions about a QuestDirect drive-thru Active Infection test you already ordered in anticipation of a trip to Hawaii, please check the status of your result in the myQuest app.